Evidence map›Paper›PMID 40520551›Full record

ArticleMaterials today. Bio2025

Self-assembled vectors derived from

Yuan Meng, Dong Han, Jiawei Xiang, Mingyuan Zhao, Zhongxian Li, Huizhen Sun, Wenxiao Yang, Fang Peng, Qiang Zhang, Yichun Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuan MengCAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
Dong HanCAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
Jiawei XiangCAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
Mingyuan ZhaoCAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
Zhongxian LiCAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
Huizhen SunCAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
Wenxiao YangHebei Key Lab of Nano-biotechnology, Hebei Key Lab of Applied Chemistry, Yanshan University, Qinhuangdao, 066004, China.
Fang PengDepartment of Critical Care Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510150, China.
Qiang ZhangHebei Key Lab of Nano-biotechnology, Hebei Key Lab of Applied Chemistry, Yanshan University, Qinhuangdao, 066004, China.
Yichun WangDepartment of Critical Care Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510150, China.
Zhuo AoCAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is an irreversible and progressive interstitial lung disease, for which no definitive cure exists so far. Although pirfenidone and nintedanib had been approved for IPF treatment, prolonged usage of these medications was often associated with adverse gastrointestinal and neurological side effects. There is still an urgent demand to develop highly effective anti-pulmonary fibrosis drugs with reduced toxicity profiles.

Indexed as

Anti-FibrosisExtracellular vesiclesHerbal medicinePulmonary fibrosisSelf-assembly

Identifiers

PMID40520551
PMCPMC12167058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.